Completed
Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
NCT01295320
- Conditions
- DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
- Locations
-
- GSK Investigational Site Hradec Králové, Czechia
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Würzburg, Bavaria, Germany
- GSK Investigational Site Hanover, Lower Saxony, Germany